{
    "clinical_study": {
        "@rank": "33454", 
        "arm_group": [
            {
                "arm_group_label": "dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "dexmedetomidine infusion from beginning of the anesthesia to just before returning to horizontal position"
            }, 
            {
                "arm_group_label": "saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Saline infusion from same time period."
            }
        ], 
        "brief_summary": {
            "textblock": "Intraocular pressure is significantly increase during robot-assisted laparoscopic radical\n      prostatectomy which is performed in a steep trendelenburg position at prolonged timeds of\n      pneumoperitoneum. Threrefore we decided to evaluate the effect of dexmedetomidine in\n      intraocular pressure during roboti-assisted laparoscopic radical prostatectomy."
        }, 
        "brief_title": "The Effect of Dexmedetomidine in Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Steep Trendelenburg Position With Penumoperitoneum in Robot Assisted Laparoscopic Prostatectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. ASA class I-II\n\n          2. obtaining written informed consent from the parents\n\n          3. aged 20-70 years who were undergoing robot- assited laparoscopic prostatectomy\n\n        Exclusion Criteria:\n\n          1. eye surgery prevoiusly\n\n          2. unstable angina or congestive heart failure\n\n          3. concomittant eye disease (glaucoma, diabetic retinophaty, cataract, retinal\n             detachment)\n\n          4. high intraocular pressure over 30mmHg after screening test.\n\n          5. uncontrolled hypertension (diastolic bp>110mmHg)\n\n          6. bradycardia under 60bpm\n\n          7. Ventricular conduction abnormality\n\n          8. hepatic failure\n\n          9. renal failure\n\n         10. drug hyperactivity\n\n         11. neurological or psychiatric illnesses\n\n         12. mental retardation\n\n         13. patients who can`t read the consent form due to illiterate or foreigner"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01898819", 
            "org_study_id": "4-2013-0195"
        }, 
        "intervention": [
            {
                "arm_group_label": "dexmedetomidine", 
                "intervention_name": "Dexmedetomidine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "saline", 
                "intervention_name": "saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Dexmedetomidine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "DEXMEDETOMIDINE", 
            "intraocular pressure"
        ], 
        "lastchanged_date": "January 23, 2014", 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "T0: Pre-induciton T1: 5min after anesthesia induction T2: 5 min after establish pneumoperitoneum T3: 15min after steep trendelenburg position T4: 30min after steep trendelenburg position T5: 45min after steep trendelenburg T6: 60min after steep trendelenburg T7: 75min after steep trendelenburg T8: 5min after returning to horizontal position T9: operation end T10: 5min after tracheal extubation T11: 60min after tracheal extubation", 
            "measure": "Influence of dexmedetomidine in intraocular pressure during robot-assisted laparoscopic prostatectomy.", 
            "safety_issue": "No", 
            "time_frame": "change of intraocular pressure from T0 to T11 for 60mins"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01898819"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}